ITPR2
Inositol 1,4,5-trisphosphate receptor type 2 (ITPR2) is a protein that in humans is encoded by the ITPR2 gene. This protein is an integral membrane protein and part of the inositol 1,4,5-trisphosphate receptor family, which plays a crucial role in intracellular calcium signaling.
Function[edit | edit source]
The ITPR2 gene encodes a receptor for inositol 1,4,5-trisphosphate (IP3), a molecule often involved in the transmission of intracellular signals. These receptors are found on the membrane of the endoplasmic reticulum (ER) and mediate the release of calcium ions from the ER when activated by IP3. Calcium ions, in turn, act as secondary messengers in various signaling pathways, influencing processes such as muscle contraction, neuronal activity, and cell growth.
Structure[edit | edit source]
The ITPR2 protein is characterized by its large size and complex structure, which includes multiple transmembrane domains, an IP3-binding domain, and a modulatory domain. This structure allows it to effectively bind IP3 and regulate calcium ion channels within the ER membrane.
Clinical Significance[edit | edit source]
Alterations in the ITPR2 gene have been associated with various diseases. Abnormalities in IP3 signaling, potentially due to mutations in the ITPR2 gene, can lead to disrupted calcium homeostasis, which has been implicated in conditions such as spinocerebellar ataxia and Gilles de la Tourette syndrome. Furthermore, the role of ITPR2 in calcium signaling makes it a potential target for therapeutic interventions in diseases characterized by abnormal calcium signaling.
Research[edit | edit source]
Research on ITPR2 has focused on understanding its role in calcium signaling pathways and its implications in disease. Studies have explored how mutations in the ITPR2 gene affect receptor function and contribute to disease pathogenesis. Additionally, there is interest in developing drugs that can modulate ITPR2 activity as a means to treat diseases associated with abnormal calcium signaling.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD